Donor monocyte-derived macrophages promote human acute graft-versus-host disease.
Bone marrow transplantation
Immunology
Macrophages
Stem cell transplantation
Transplantation
Journal
The Journal of clinical investigation
ISSN: 1558-8238
Titre abrégé: J Clin Invest
Pays: United States
ID NLM: 7802877
Informations de publication
Date de publication:
01 09 2020
01 09 2020
Historique:
received:
10
10
2019
accepted:
19
05
2020
pubmed:
27
5
2020
medline:
9
2
2021
entrez:
27
5
2020
Statut:
ppublish
Résumé
Myelopoiesis is invariably present and contributes to pathology in animal models of graft-versus-host disease (GVHD). In humans, a rich inflammatory infiltrate bearing macrophage markers has also been described in histological studies. In order to determine the origin, functional properties, and role in pathogenesis of these cells, we isolated single-cell suspensions from acute cutaneous GVHD and subjected them to genotype, transcriptome, and in vitro functional analysis. A donor-derived population of CD11c+CD14+ cells was the dominant population of all leukocytes in GVHD. Surface phenotype and NanoString gene expression profiling indicated the closest steady-state counterpart of these cells to be monocyte-derived macrophages. In GVHD, however, there was upregulation of monocyte antigens SIRPα and S100A8/9 transcripts associated with leukocyte trafficking, pattern recognition, antigen presentation, and costimulation. Isolated GVHD macrophages stimulated greater proliferation and activation of allogeneic T cells and secreted higher levels of inflammatory cytokines than their steady-state counterparts. In HLA-matched mixed leukocyte reactions, we also observed differentiation of activated macrophages with a similar phenotype. These exhibited cytopathicity to a keratinocyte cell line and mediated pathological damage to skin explants independently of T cells. Together, these results define the origin, functional properties, and potential pathogenic roles of human GVHD macrophages.
Identifiants
pubmed: 32453711
pii: 133909
doi: 10.1172/JCI133909
pmc: PMC7456218
doi:
pii:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
4574-4586Subventions
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Wellcome Trust
ID : W T097941
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 101155/Z/13/Z
Pays : United Kingdom
Organisme : Department of Health
Pays : United Kingdom
Commentaires et corrections
Type : CommentIn
Références
J Immunol. 2014 Oct 1;193(7):3355-65
pubmed: 25187661
Mucosal Immunol. 2013 May;6(3):498-510
pubmed: 22990622
J Exp Med. 2009 Feb 16;206(2):387-98
pubmed: 19171763
J Immunol. 2006 Oct 1;177(7):4414-25
pubmed: 16982876
Blood. 2009 Oct 1;114(14):3113-6
pubmed: 19643987
Immunity. 2014 Feb 20;40(2):274-88
pubmed: 24530056
J Clin Invest. 1998 Nov 15;102(10):1882-91
pubmed: 9819375
Am J Respir Crit Care Med. 2011 May 1;183(9):1262-79
pubmed: 21531955
Transplantation. 2009 Dec 15;88(11):1261-72
pubmed: 19996925
Biol Blood Marrow Transplant. 2006 Feb;12(2):152-9
pubmed: 16443513
J Clin Invest. 2007 Sep;117(9):2517-25
pubmed: 17786242
N Engl J Med. 2017 Nov 30;377(22):2167-2179
pubmed: 29171820
J Exp Med. 2011 Feb 14;208(2):227-34
pubmed: 21242295
Blood. 2011 Jan 13;117(2):697-707
pubmed: 20944073
J Exp Med. 2006 Jan 23;203(1):27-33
pubmed: 16390938
Nat Med. 2011 Nov 29;18(1):135-42
pubmed: 22127134
J Exp Med. 2009 Dec 21;206(13):3089-100
pubmed: 19995948
Immunity. 2017 Sep 19;47(3):582-596.e6
pubmed: 28930664
Nat Med. 2004 May;10(5):510-7
pubmed: 15098028
J Exp Med. 2009 Feb 16;206(2):371-85
pubmed: 19171766
Sci Transl Med. 2015 Apr 1;7(281):281ra42
pubmed: 25834108
J Invest Dermatol. 2010 Oct;130(10):2412-22
pubmed: 20555352
PLoS One. 2014 May 07;9(5):e96252
pubmed: 24806147
Cell. 2017 Jun 29;170(1):127-141.e15
pubmed: 28666115
Biol Blood Marrow Transplant. 2017 Dec;23(12):2057-2064
pubmed: 28807771
Science. 2011 Jun 10;332(6035):1284-8
pubmed: 21566158
Biotechniques. 2003 Feb;34(2):374-8
pubmed: 12613259
J Invest Dermatol. 2014 Apr;134(4):965-974
pubmed: 24352044
Transpl Immunol. 2018 Oct;50:48-54
pubmed: 29906586
Immunity. 2017 Dec 19;47(6):1037-1050.e6
pubmed: 29221729
Front Immunol. 2016 Nov 29;7:539
pubmed: 27965667
Blood. 2011 Dec 8;118(24):6426-37
pubmed: 21963602
JCI Insight. 2018 Mar 8;3(5):
pubmed: 29515032
J Immunol. 2015 Dec 15;195(12):5795-804
pubmed: 26538394
Blood. 2016 Jun 16;127(24):2963-70
pubmed: 27030390
Exp Dermatol. 2011 Feb;20(2):145-6
pubmed: 20707812
Blood. 2007 Dec 1;110(12):3827-32
pubmed: 17766680
Immunity. 2013 Feb 21;38(2):336-48
pubmed: 23352235
Nat Med. 2004 Sep;10(9):987-92
pubmed: 15286785
Transplantation. 2014 Sep 15;98(5):563-8
pubmed: 24717220
J Exp Med. 2011 May 9;208(5):1069-82
pubmed: 21536742
Sci Transl Med. 2018 Nov 28;10(469):
pubmed: 30487251
Blood. 2005 Mar 1;105(5):2227-34
pubmed: 15522961
J Exp Med. 1992 Feb 1;175(2):405-13
pubmed: 1732411
Immunity. 2012 Jul 27;37(1):60-73
pubmed: 22795876
Biol Blood Marrow Transplant. 2017 Sep;23(9):1417-1421
pubmed: 28606646
Blood. 2014 Jan 9;123(2):290-9
pubmed: 24255916
Immunity. 2014 Sep 18;41(3):465-477
pubmed: 25200712
J Exp Med. 2015 Jul 27;212(8):1303-21
pubmed: 26169940
Bone Marrow Transplant. 2015 Aug;50(8):1135-7
pubmed: 25961771
J Clin Invest. 2020 Sep 1;130(9):4624-4636
pubmed: 32516138
Blood. 2010 Dec 16;116(25):5748-51
pubmed: 20864580
Mol Biosyst. 2016 Feb;12(2):477-9
pubmed: 26661513
Eur J Immunol. 1992 Jul;22(7):1891-7
pubmed: 1378023
PLoS One. 2012;7(3):e33556
pubmed: 22438948
Scand J Immunol. 2011 Aug;74(2):186-94
pubmed: 21392045
J Exp Med. 2018 Feb 5;215(2):441-458
pubmed: 29273642
J Immunol. 1986 Jul 15;137(2):512-8
pubmed: 3722815
Nat Med. 2002 Apr;8(4):410-4
pubmed: 11927949
Blood. 2010 Nov 11;116(19):3955-63
pubmed: 20682855
Exp Cell Biol. 1987;55(6):295-304
pubmed: 3450546
J Clin Invest. 2014 Oct;124(10):4266-80
pubmed: 25157821